Development and validation of a blood biomarker risk prediction model for postmenopausal endometrioid endometrial cancer. [PDF]
Xu H +7 more
europepmc +1 more source
Enhancing the positive predictive value of early-stage ovarian cancer detection using a two-step machine learning framework. [PDF]
Mikami M +23 more
europepmc +1 more source
Blood-based inflammatory biomarkers in ovarian cancer: addressing the challenge of early detection, metastasis, and prognostic stratification. [PDF]
Obeagu EI.
europepmc +1 more source
MRI-based deep-learning radiomics nomogram for differentiating FIGO 2023 stage I from stage II-IV endometrial cancer: a multicenter study. [PDF]
Chu X +8 more
europepmc +1 more source
Expression levels of serum SCC, HE4, and TSGF in cervical cancer patients and their correlation with recurrence: a retrospective study. [PDF]
Wei Y, Song F, Wang W.
europepmc +1 more source
Serum human epididymis protein 4, endocan, sialyl-Tn, and neopterin in endometrial cancer: a prospective case-control study. [PDF]
Toyran A +9 more
europepmc +1 more source
Serum HE4 and polymorphisms in MMP9 and MMP13 associated with survival outcome in patients with endometrial carcinoma: a retrospective cohort study and nomogram development. [PDF]
Li R +7 more
europepmc +1 more source
Portable electrochemical immunosensor for point-of-care testing of ovarian cancer biomarker HE4 in commercial human blood serum samples. [PDF]
Yılmaz Çılçar M, Bilgi Kamaç M.
europepmc +1 more source

